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Medicine and the Media
The AdWatch section of the Healthy Skepticism website (www.healthyskepticism.org/adwatch.asp) 
aims to improve medical decision-making by illuminating the techniques used in drug advertising. 
AdWatch draws on 20 years of dialogue about drug promotion plus ideas from many disciplines, 
especially logic, psychology and marketing. Med J Aust 2003; 179: 644-645
A small group know  as Healthy Skepticism . . . has consistently
and insistently drawn the attention of producers to promotional
malpractice, calling for (and often securing) correction. These
organisations [Healthy Skepticism, Médecins Sans Frontières
and Health Action International] are small, but they are capable;
they bear malice towards no one, and they are honest. If industry
is indeed persuaded to face up to its social responsibilities in the
coming years it may well be because of these associations and
others like them.1 Graham Dukes (Professor of Drug Policy
Studies, University of Oslo, Norway)
THE QUALITY OF CARE delivered by doctors and our
consequent incomes depend on our decision-making skills in
the face of information and promotion of variable quality.
However, few doctors have much training in the basic sciences
for decision-making, such as logic and psychology. A database
of 2178 references on drug promotion compiled by the World
Health Organization provides evidence that many doctors are
more vulnerable to being misled than they realise.2
Healthy Skepticism is an international organisation based
in Australia that aims to improve health by reducing harm
from misleading drug promotion. In October 2003, Healthy
Skepticism launched AdWatch, a monthly webpage that
explains the techniques used in drug advertisements.3 The
story of Healthy Skepticism’s predecessor, MaLAM (the
Medical Lobby for Appropriate Marketing), was told in the
1997 Christmas issue of the Journal.4 This update describes
the ideas behind the transition from MaLAM to Healthy
Skepticism and the launch of AdWatch.
From MaLAM to Healthy Skepticism
In the 1980s, open letters from MaLAM achieved improve-
ments in advertising and some drugs were withdrawn.5
During the 1990s, there were fewer obviously inappropriate
drugs to target. Although many serious problems with mis-
leading promotion persist,6 they are more subtle and thus less
amenable to open-letter campaigns. To understand these
problems better, we developed a stronger multidisciplinary
team with expertise in medicine, marketing, psychology,
pharmacy, pharmacology, statistics and logic.7
We were inspired to change our name to Healthy Skepti-
cism by a 1963 speech from drug advertising executive Pierre
Garai.8 Garai urged doctors to stop blaming drug companies
for misleading drug promotion and argued that the quality of
drug promotion depends on the quality of medical decision-
making; “. . . indeed, [if] candor, accuracy, scientific com-
pleteness, and a permanent ban on cartoons came to be
essential for the successful promotion of [prescription] drugs,
advertising would have no choice but to comply”. Garai
challenged doctors to accept responsibility for improving their
decision-making and to develop healthy scepticism.
We accept that effective promotion is a mirror to our souls,
reflecting how we really make decisions. The image it reveals
differs from what we would prefer to believe about ourselves.
However, accepting our human limitations is the best first
step towards improved medical care. Consequently, we
accept Garai’s challenge, but we feel that blaming the targets
of promotion for human vulnerability to promotional tech-
niques is not helpful. Many techniques have been effective in
fooling many of the people much of the time for centuries;9
others are products of recent sophisticated research on ways
to increase sales.10,11 We prefer to focus on changing the
current system in which misleading promotion leads to
inappropriate prescribing and higher profits for drug compa-
nies, thus funding more misleading promotion. This vicious
cycle harms patients and may reduce incomes for doctors and
drug companies in the long run.
The concept of healthy scepticism
There were two schools of extreme scepticism in ancient
Greece. The Pyrrhonian Sceptics suspended judgement on
all claims, including the Academic Sceptics’ claim that noth-
ing could be known for certain. Moderate healthy scepticism
started with the 16th century theologian Castellio, who
advocated accepting reasonable beliefs rather than aiming for
certainty.12
In the 1990s, a US business academic developed a ques-
tionnaire for measuring scepticism.13 She characterised scep-
tics as slow to accept claims or form judgements, but keen to
ask questions in pursuit of knowledge and understanding,
and found that sceptical auditors were more effective and
efficient at detecting problems in company accounts.
Thus, healthy scepticism involves selectively accepting
claims that are justified by good evidence or argument, while
resisting those that are not.
Understanding misleading promotion
From Aristotle onward, logicians have observed many types of
misleading arguments, which are now called fallacies.9 Psy-
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chologists have studied similar concepts, calling them heuris-
tics, biases and influence techniques.14,15 We prefer the term
shortcuts. These are quick and easy processes for reaching
conclusions that are correct only when common assumptions
are justified. For example, “newer is better” is usually a
reliable shortcut for choosing the best vegetables or comput-
ers, but often unreliable when choosing drugs. It is common
to assume that most new drugs are superior, but only about
3% of new drugs offer real advances.16 It is normal to use
shortcuts when faced with inadequate time, skills or resources
to examine the evidence fully, or when the evidence required is
not available. Some common shortcuts are listed in the Box.
Drug companies are skilled at influencing prescribing by
triggering the shortcuts that doctors rely on. For example, the
“experts know best” shortcut underpins company-funded
education. Drug companies also carefully choose visual and
verbal images that appeal to our normal desires for power,
respect, wealth, speed, simplicity, security and sex.10
There is evidence that advertising can be effective at
influencing behaviour despite being given little attention.11
Subtle messages that might be rejected if carefully considered
can sneak “under the radar” to create links between the
indication, the product and the motivation. Repetition
strengthens these links so that the product moves up the
mental agenda to be the first to come to mind during
decision-making.
Promotional techniques are tools for good or ill depending
on how they are used and what they are used for. Shortcuts
often lead to correct conclusions, and desires can be appro-
priate. It is not possible to advance good causes without using
promotion. To be successful at advancing the aims of Healthy
Skepticism, we have to use the same techniques that we want
people to be more sceptical about. However, we aim to use
promotion honestly. This article uses all the shortcuts listed in
the Box and appeals to most of the desires listed above.
Developing healthy scepticism with AdWatch
Healthy scepticism is difficult to promote because most people
are confident that they already have an optimal amount. It is
common to believe that only other people are susceptible to
being misled. Dispelling this illusion of unique invulnerability
is the key to improving discrimination between misleading and
justified claims.15 One effective method for dispelling this
illusion is to mislead people and then show them how they have
been deceived. In one study, hospital pharmacists used the
techniques of drug company representatives to mislead medical
students and then explained the techniques.17 After the inter-
vention, the students were less certain about the value of
interactions with drug company representatives.
We hope AdWatch will produce similar benefits by explain-
ing the logical, psychological and pharmacological techniques
used in drug advertisements. We will also use feedback from
visitors to the AdWatch section of the Healthy Skepticism
website (www.healthyskepticism.org/adwatch.asp) for dia-
logue with the companies responsible for the advertisements,
the Medicines Australia Code of Conduct Committee and
the government regulatory agencies.
We have started with advertisements targeting Australian
general practitioners but hope to develop editions for special-
ists and for other countries. Initial feedback to AdWatch from
general practitioners, specialists, pharmacists and members
of the public worldwide has been positive. An Australian
doctor commented: “Unfortunately [the advertisement] had
me sucked in for a period, but no longer.”
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Commonly used shortcuts for choosing therapies
■ Newer is better.
■ Experts know best.
■ If there is mechanism for how it works, it works.
■ If my peers are using a therapy, so should I.
■ If the manufacturers give gifts, I should support them in return.
■ If I see changes after prescribing a therapy, that therapy must be 
the cause.
